In 13 (3.2%) patients, serum TBEV IgG antibodies were below the cut-off value early in the second phase of TBE; 12 had IgM antibodies to TBEV in serum at this time point, and all of them later seroconverted. This evidence concerns the gene CD40LG and tick-borne encephalitis.